safranal has been researched along with Disease Models, Animal in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Lin, Z; Teng, C; Wang, J; Wang, L; Wu, J; Wu, L; Zhang, Z | 1 |
| Abd El-Salam, DM; Hussein, RM; Rizk, SM; Shehata, NI | 1 |
| Chu, X; Guan, S; Jin, W; Wang, H; Xue, Y; Zhang, J; Zhang, Y | 1 |
| Fu, W; Lertnimitphun, P; Lu, Y; Pei, W; Xu, H; Yang, B; Yuan, M; Zhang, W; Zhang, X; Zheng, C; Zhou, H | 1 |
| Xi, G; Zhao, Y | 1 |
| Eghdami, K; Erfanparast, A; Farshid, AA; Samadi, F; Tamaddonfard, E | 1 |
| Bukhari, SI; Dhar, MK; Kaul, S; Pattnaik, B; Rayees, S | 1 |
| Broadhead, GK; Chang, A; Grigg, J; McCluskey, P | 1 |
| Dang, X; Fan, L; Ma, J; Song, J; Wang, K; Zhang, C; Zou, Y | 1 |
| Cortez, MA; Hosseinzadeh, H; Liu, D; Sadeghnia, HR; Snead, OC | 1 |
| Amin, B; Hosseinzadeh, H | 1 |
| Cuenca, N; Esquiva, G; Fernández-Sánchez, L; Lax, P; Martín-Nieto, J; Pinilla, I | 1 |
1 review(s) available for safranal and Disease Models, Animal
| Article | Year |
|---|---|
Efficacy and Safety of Saffron Supplementation: Current Clinical Findings.
Topics: Affect; Animals; Antioxidants; Cardiovascular System; Carotenoids; Clinical Trials as Topic; Cognition; Crocus; Cyclohexenes; Disease Models, Animal; Humans; Oxidative Stress; Phytotherapy; Plant Preparations; Reproduction; Terpenes; Vision, Ocular; Vitamin A; Zeaxanthins | 2016 |
11 other study(ies) available for safranal and Disease Models, Animal
| Article | Year |
|---|---|
Safranal Treatment Induces Sirt1 Expression and Inhibits Endoplasmic Reticulum Stress in Mouse Chondrocytes and Alleviates Osteoarthritis Progression in a Mouse Model.
Topics: Animals; Apoptosis; Chondrocytes; Cyclohexenes; Disease Models, Animal; Endoplasmic Reticulum Stress; Mice; Osteoarthritis; Sirtuin 1; Terpenes; tert-Butylhydroperoxide | 2022 |
Effect of safranal or candesartan on 3-nitropropionicacid-induced biochemical, behavioral and histological alterations in a rat model of Huntington's disease.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Corpus Striatum; Disease Models, Animal; Huntington Disease; Motor Activity; Neuroprotective Agents; Nitro Compounds; Propionates; Rats; Rats, Wistar | 2023 |
Safranal, an active constituent of saffron, ameliorates myocardial ischemia via reduction of oxidative stress and regulation of Ca
Topics: Animals; Calcium; Cardiotonic Agents; Cells, Cultured; Crocus; Cyclohexenes; Disease Models, Animal; Isoproterenol; Male; Malondialdehyde; Myocardial Contraction; Myocardial Ischemia; Myocardium; Oxidative Stress; Phytotherapy; Rats, Sprague-Dawley; Superoxide Dismutase; Terpenes | 2020 |
Safranal Alleviated OVA-Induced Asthma Model and Inhibits Mast Cell Activation.
Topics: Allergens; Animals; Anti-Inflammatory Agents; Asthma; Cell Degranulation; Cyclohexenes; Cytokines; Disease Models, Animal; Disease Susceptibility; Female; Immunoglobulin E; Inflammation Mediators; Mast Cells; Mice; NF-kappa B; Ovalbumin; Signal Transduction; Terpenes | 2021 |
Safranal-promoted differentiation and survival of dopaminergic neurons in an animal model of Parkinson's disease.
Topics: Animals; Cell Differentiation; Cyclohexenes; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Green Fluorescent Proteins; Neural Stem Cells; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Stem Cell Transplantation; Terpenes; Tyrosine 3-Monooxygenase | 2018 |
Comparison of the effects of crocin, safranal and diclofenac on local inflammation and inflammatory pain responses induced by carrageenan in rats.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Carotenoids; Carrageenan; Cyclohexenes; Diclofenac; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Hyperalgesia; Inflammation; Male; Neutrophil Infiltration; Pain; Pain Threshold; Rats; Rats, Wistar; Terpenes; Time Factors | 2013 |
Safranal of Crocus sativus L. inhibits inducible nitric oxide synthase and attenuates asthma in a mouse model of asthma.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Asthma; Cells, Cultured; Crocus; Cyclohexenes; Cytochromes c; Cytokines; Disease Models, Animal; Humans; Lung; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Peroxynitrous Acid; Plant Extracts; Terpenes | 2015 |
Neuroprotective effects of safranal in a rat model of traumatic injury to the spinal cord by anti-apoptotic, anti-inflammatory and edema-attenuating.
Topics: Animals; Apoptosis; Cyclohexenes; Disease Models, Animal; Edema; Humans; Inflammation; Interleukin-10; Male; Neurons; Neuroprotective Agents; Rats; Spinal Cord Injuries; Terpenes; Tumor Necrosis Factor-alpha | 2015 |
Antiabsence effects of safranal in acute experimental seizure models: EEG and autoradiography.
Topics: Animals; Autoradiography; Binding Sites; Brain; Crocus; Cyclohexenes; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy, Absence; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Receptors, GABA-A; Terpenes | 2008 |
Evaluation of aqueous and ethanolic extracts of saffron, Crocus sativus L., and its constituents, safranal and crocin in allodynia and hyperalgesia induced by chronic constriction injury model of neuropathic pain in rats.
Topics: Acetone; Amines; Analgesics; Animals; Behavior, Animal; Carotenoids; Constriction; Crocus; Cyclohexanecarboxylic Acids; Cyclohexenes; Disease Models, Animal; Dose-Response Relationship, Drug; Gabapentin; gamma-Aminobutyric Acid; Hot Temperature; Hyperalgesia; Male; Neuralgia; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Terpenes; Walking | 2012 |
Safranal, a saffron constituent, attenuates retinal degeneration in P23H rats.
Topics: Animals; Cell Communication; Crocus; Cyclohexenes; Disease Models, Animal; Neuroprotective Agents; Photoreceptor Cells; Rats; Retina; Retinal Bipolar Cells; Retinal Degeneration; Retinal Horizontal Cells; Retinitis Pigmentosa; Synaptic Transmission; Terpenes | 2012 |